BibTex RIS Cite

New vaccines for adolescents

Year 2011, , 39 - 42, 01.03.2011
https://doi.org/10.4274/tpa.46.31

Abstract

@font face { font family: Times ; }p MsoNormal li MsoNormal div MsoNormal { margin: 0cm 0cm 0 0001pt; font size: 12pt; font family: Times New Roman ; }div Section1 { page: Section1; }

References

  • Arısoy ES. Ergenlerde aşılama. İçinde: Salman N (ed). Güncel aşılama. İstanbul: Medya tower tanıtım ve yayıncılık hizmetleri, 2008:117-23.
  • CDC. The Advisory Committee on Immunization Practice. Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. MMWR Morb Mortal Wkly Rep 2006; 55: 1-34.
  • Committee on Infectious Diseases Recommended childhood immunization Schedule-United States. Pediatrics 2001; 107: 202-4.
  • West DJ, Margolis HS. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 1992; 11: 866-74. (Abstract)
  • Centers for Disease Control and Prevention, Atlanta Viral Hepatitis Surveillance Report No. 56. 1995; 36: 21-32.
  • Edwards S, Diaz A. Adolescents and Immunization: Tips for the primary care provider. Mount Sinai J Med 2004; 3: 162-5. (Abstract)
  • Gershon AA, LaRussa P, Hardy I, et al. Varicella vaccine: theAmerican experience. J Infect Dis 1992; 166: 63-8. (PDF)
  • Yusuf H, Averhoff F, Smith N, Brink E. Adolescent immunization: rationale, recommendations and implementation strategies. Pediatr Ann 1998; 27: 436-44. (Abstract)
  • Somer A. Meningokok Aşıları. İçinde: Salman N (ed). Güncel aşılama. İstanbul: Medya tower tanıtım ve yayıncılık hizmetleri, 2008:79-95.
  • Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007: 297: 813-9. (Abstract) / (Full Text) / (PDF)
  • Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 23: 1-24.
  • Bosch FX, Castellsague X, de Sanjose S. HPV and cervical cancer: screening or vaccination? British J Cancer 2008; 98: 15-21. (Abstract) / (Full Text) / (PDF)
  • Bornstein J. Human papillomavirus vaccine: the beginning of the end for cervical cancer. Isr Med Assoc J 2007; 9: 156-8. (Abstract)
  • The Future II Study Group. Quadrivalent vaccine against humanpapillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915-27. (Abstract) / (Full Text) / (PDF)
  • Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow up from a randomised control trial. Lancet 2006; 367: 1247-55. (Abstract) / (Full Text) / (PDF)
  • Olsson SE, Villa LL, Costa RL, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Vaccine 2007; 25: 4931-9. (Abstract) / (Full Text) / (PDF)
  • Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA ed (s). Vaccines. Fourth ed. Philadelphia: WB Saunders, 1999: 553-607.
  • American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK ed (s). Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village IL: American Academy of Pediatrics; 2006: 525-37.

Ergenlik çağında yeni aşılar

Year 2011, , 39 - 42, 01.03.2011
https://doi.org/10.4274/tpa.46.31

Abstract

@font face { font family: Times ; }p MsoNormal li MsoNormal div MsoNormal { margin: 0cm 0cm 0 0001pt; font size: 12pt; font family: Times New Roman ; }div Section1 { page: Section1; }

References

  • Arısoy ES. Ergenlerde aşılama. İçinde: Salman N (ed). Güncel aşılama. İstanbul: Medya tower tanıtım ve yayıncılık hizmetleri, 2008:117-23.
  • CDC. The Advisory Committee on Immunization Practice. Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. MMWR Morb Mortal Wkly Rep 2006; 55: 1-34.
  • Committee on Infectious Diseases Recommended childhood immunization Schedule-United States. Pediatrics 2001; 107: 202-4.
  • West DJ, Margolis HS. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 1992; 11: 866-74. (Abstract)
  • Centers for Disease Control and Prevention, Atlanta Viral Hepatitis Surveillance Report No. 56. 1995; 36: 21-32.
  • Edwards S, Diaz A. Adolescents and Immunization: Tips for the primary care provider. Mount Sinai J Med 2004; 3: 162-5. (Abstract)
  • Gershon AA, LaRussa P, Hardy I, et al. Varicella vaccine: theAmerican experience. J Infect Dis 1992; 166: 63-8. (PDF)
  • Yusuf H, Averhoff F, Smith N, Brink E. Adolescent immunization: rationale, recommendations and implementation strategies. Pediatr Ann 1998; 27: 436-44. (Abstract)
  • Somer A. Meningokok Aşıları. İçinde: Salman N (ed). Güncel aşılama. İstanbul: Medya tower tanıtım ve yayıncılık hizmetleri, 2008:79-95.
  • Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007: 297: 813-9. (Abstract) / (Full Text) / (PDF)
  • Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 23: 1-24.
  • Bosch FX, Castellsague X, de Sanjose S. HPV and cervical cancer: screening or vaccination? British J Cancer 2008; 98: 15-21. (Abstract) / (Full Text) / (PDF)
  • Bornstein J. Human papillomavirus vaccine: the beginning of the end for cervical cancer. Isr Med Assoc J 2007; 9: 156-8. (Abstract)
  • The Future II Study Group. Quadrivalent vaccine against humanpapillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915-27. (Abstract) / (Full Text) / (PDF)
  • Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow up from a randomised control trial. Lancet 2006; 367: 1247-55. (Abstract) / (Full Text) / (PDF)
  • Olsson SE, Villa LL, Costa RL, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Vaccine 2007; 25: 4931-9. (Abstract) / (Full Text) / (PDF)
  • Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA ed (s). Vaccines. Fourth ed. Philadelphia: WB Saunders, 1999: 553-607.
  • American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK ed (s). Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village IL: American Academy of Pediatrics; 2006: 525-37.
There are 18 citations in total.

Details

Primary Language Turkish
Journal Section Review
Authors

Yıldız Camcıoğlu This is me

Publication Date March 1, 2011
Published in Issue Year 2011

Cite

APA Camcıoğlu, Y. (2011). Ergenlik çağında yeni aşılar. Türk Pediatri Arşivi, 46(11), 39-42. https://doi.org/10.4274/tpa.46.31
AMA Camcıoğlu Y. Ergenlik çağında yeni aşılar. Türk Pediatri Arşivi. March 2011;46(11):39-42. doi:10.4274/tpa.46.31
Chicago Camcıoğlu, Yıldız. “Ergenlik çağında Yeni aşılar”. Türk Pediatri Arşivi 46, no. 11 (March 2011): 39-42. https://doi.org/10.4274/tpa.46.31.
EndNote Camcıoğlu Y (March 1, 2011) Ergenlik çağında yeni aşılar. Türk Pediatri Arşivi 46 11 39–42.
IEEE Y. Camcıoğlu, “Ergenlik çağında yeni aşılar”, Türk Pediatri Arşivi, vol. 46, no. 11, pp. 39–42, 2011, doi: 10.4274/tpa.46.31.
ISNAD Camcıoğlu, Yıldız. “Ergenlik çağında Yeni aşılar”. Türk Pediatri Arşivi 46/11 (March 2011), 39-42. https://doi.org/10.4274/tpa.46.31.
JAMA Camcıoğlu Y. Ergenlik çağında yeni aşılar. Türk Pediatri Arşivi. 2011;46:39–42.
MLA Camcıoğlu, Yıldız. “Ergenlik çağında Yeni aşılar”. Türk Pediatri Arşivi, vol. 46, no. 11, 2011, pp. 39-42, doi:10.4274/tpa.46.31.
Vancouver Camcıoğlu Y. Ergenlik çağında yeni aşılar. Türk Pediatri Arşivi. 2011;46(11):39-42.